RACHEL ZIMMER: Open Payments
NPI 1790403012 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,817 in 93 payments from 14 companies in 2025. Trend: 2023 $3,085 · 2024 $4,466 · 2025 $3,817
Food & beverage: $2,489Travel & lodging: $1,328
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 30 | $2,472 |
| Edwards Lifesciences Corporation | 28 | $484 |
| Abbott Laboratories | 13 | $401 |
| Novartis Pharmaceuticals Corporation | 7 | $122 |
| PFIZER INC. | 3 | $63 |
| BridgeBio Pharma, Inc. | 2 | $59 |
| SCPHARMACEUTICALS INC. | 2 | $40 |
| ABIOMED | 1 | $34 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $32 |
| HEARTFLOW, INC. | 1 | $27 |
Products named: COREVALVE EVOLUT R, SAPIEN 3 Ultra RESILIA, CARDIOMEMS, TRICLIP, LEQVIO, Attruby, VYNDAQEL, FUROSCIX.
Industry payments across NE — which companies pay providers there.
